{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/BSEM",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# BioStem Technologies, Inc. (NASDAQ: BSEM) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nBioStem Technologies, Inc. is listed on NASDAQ under the ticker BSEM. Its ISIN is US0906842002 and its LEI is 54930046GKCRPVZDQH50. Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States — Florida. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 67 filings across 32 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 27 regulatory filings, 27 directors' dealings, 8 prospectuses, 3 corporate news items and 2 results. The median gap between filing days is 4 days. The latest filing is a regulatory filing dated 2026-11-05, 3 days before the record date of 2026-11-08. On NASDAQ the median filings in the window is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days. On the sector the median filings is 65.5, the median cadence gap is 5.5 days and the median latency is 4.0 days. The issuer's 67 filings are above the NASDAQ median of 52 and above the sector median of 65.5.\n\n## Auditor\n\nThe auditor is not on the record, because the latest annual report cover carries no auditor name tag. The auditor's location is not on the record. The record holds no auditor changes.\n\n## Events and halts\n\nThe record holds one listing event, dated 2026-08-06. It holds no delisting and no name change. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read.\n\n## Open research\n\nThe record holds one openly published research note: Zacks Small-Cap Research, dated 2024-08-13.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe sealed years that hold the issuer are 2021, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began 2026-09-12.\n\n## Sources\n\n9 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)\n- https://data.sec.gov/submissions/CIK0001658678.json (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/BSEM (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://ir.biostemtechnologies.com/assets/uploads/2024/08/Zacks_SCR_Research_08132024_BSEM_Sorensen.pdf (open research)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/BSEM (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "market": "US",
    "reason": "no dei:AuditorName tag on the latest annual report cover (foreign private issuers and older filings carry none)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "US",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "US",
    "state": "not_on_record"
   },
   "changes": []
  },
  "cmr": "us-cm-kg/NASDAQ/BSEM",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://ir.biostemtechnologies.com/analyst/",
     "result": "not readable by this rail (403)"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 176,
     "median_cadence_gap_days": 5.5,
     "median_filings": 65.5,
     "median_latency_days": 4,
     "name": "2836 Biological Products, (No Diagnostic Substances)"
    }
   },
   "by_type": {
    "corporate_news": 3,
    "directors_dealings": 27,
    "prospectus": 8,
    "regulatory_filing": 27,
    "results": 2
   },
   "cadence_median_gap_days": 4,
   "filing_days": 32,
   "filings": 67,
   "latency_days": 3,
   "latest": [
    {
     "category": "SCHEDULE 13G",
     "date": "2026-11-05",
     "source": "https://www.sec.gov/Archives/edgar/data/1658678/000119312526448634/xslSCHEDULE_13G_X02/primary_doc.xml",
     "title": "SCHEDULE 13G",
     "type": "regulatory_filing"
    },
    {
     "category": "4",
     "date": "2026-11-03",
     "source": "https://www.sec.gov/Archives/edgar/data/1658678/000119312526445456/xslF345X06/ownership.xml",
     "title": "4 — 4",
     "type": "directors_dealings"
    },
    {
     "category": "424B3",
     "date": "2026-10-13",
     "source": "https://www.sec.gov/Archives/edgar/data/1658678/000121390026109034/ea0308412-424b3_biostem.htm",
     "title": "424B3 — PROSPECTUS",
     "type": "prospectus"
    },
    {
     "category": "EFFECT",
     "date": "2026-10-09",
     "source": "https://www.sec.gov/Archives/edgar/data/1658678/999999999526003213/xslEFFECTX01/primary_doc.xml",
     "title": "EFFECT (items ,,)",
     "type": "regulatory_filing"
    },
    {
     "category": "D",
     "date": "2026-10-09",
     "source": "https://www.sec.gov/Archives/edgar/data/1658678/000121390026108470/xslFormDX01/primary_doc.xml",
     "title": "D (items 06b)",
     "type": "regulatory_filing"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/BSEM",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (ISINs mapped to the LEI)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest",
    "state": "sourced",
    "value": "US0906842002"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001658678.json",
    "state": "sourced",
    "value": "United States — Florida"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-08",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN US0906842002)",
    "state": "sourced",
    "value": "54930046GKCRPVZDQH50"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001658678.json",
    "state": "sourced",
    "value": "BioStem Technologies, Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001658678.json",
    "state": "sourced",
    "value": "2836 Biological Products, (No Diagnostic Substances)"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001658678.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "BSEM"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [
    {
     "date": "2026-08-06",
     "source": "https://www.sec.gov/Archives/edgar/data/1658678/000135445726000762/BSEM_Form10_Cert_0001658678.pdf",
     "title": "CERT"
    }
   ],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:9712777cb815df41a265b7cf9626ccee8e04b49c3f1df6e3bf726017eb6c6d8b",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [
    {
     "date": "2024-08-13",
     "kind": "issuer-sponsored",
     "publisher": "Zacks Small-Cap Research",
     "read_by": "the note's link answers (200 application/pdf); a document, not read as text",
     "read_date": "2026-11-11",
     "source": "https://ir.biostemtechnologies.com/assets/uploads/2024/08/Zacks_SCR_Research_08132024_BSEM_Sorensen.pdf",
     "state": "sourced",
     "title": "BSEM: Growth Continue to Accelerate"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/BSEM",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:9712777cb815df41a265b7cf9626ccee8e04b49c3f1df6e3bf726017eb6c6d8b",
 "path": "/us/NASDAQ/BSEM",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "BioStem Technologies, Inc. is listed on NASDAQ under the ticker BSEM. Its ISIN is US0906842002 and its LEI is 54930046GKCRPVZDQH50. Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States — Florida. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 67 filings across 32 filing days in the window 2025-11-08 to 2026-11-08. The filings comprise 27 regulatory filings, 27 directors' dealings, 8 prospectuses, 3 corporate news items and 2 results. The median gap between filing days is 4 days. The latest filing is a regulatory filing dated 2026-11-05, 3 days before the record date of 2026-11-08. On NASDAQ the median filings in the window is 52, the median cadence gap is 6.0 days and the median latency is 5.0 days. On the sector the median filings is 65.5, the median cadence gap is 5.5 days and the median latency is 4.0 days. The issuer's 67 filings are above the NASDAQ median of 52 and above the sector median of 65.5.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor is not on the record, because the latest annual report cover carries no auditor name tag. The auditor's location is not on the record. The record holds no auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds one listing event, dated 2026-08-06. It holds no delisting and no name change. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04. The chapter's orderability section carries no client categories, so the outcome cannot name its client category.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds one openly published research note: Zacks Small-Cap Research, dated 2024-08-13.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The sealed years that hold the issuer are 2021, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "9 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001658678.json"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/BSEM"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://ir.biostemtechnologies.com/assets/uploads/2024/08/Zacks_SCR_Research_08132024_BSEM_Sorensen.pdf"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/BSEM"
  }
 ],
 "title": "BioStem Technologies, Inc. (BSEM) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}